Cargando…
De-labelling penicillin allergy in acutely hospitalized patients: a pilot study
BACKGROUND: Penicillin allergy prevalence is internationally reported to be around 10%. However, the majority of patients who report a penicillin allergy do not have a clinically significant hypersensitivity. Few patients undergo evaluation, which leads to overuse of broad-spectrum antibiotics. The...
Autores principales: | Steenvoorden, Linde, Bjoernestad, Erik Oeglaend, Kvesetmoen, Thor-Agne, Gulsvik, Anne Kristine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8527685/ https://www.ncbi.nlm.nih.gov/pubmed/34670500 http://dx.doi.org/10.1186/s12879-021-06794-1 |
Ejemplares similares
-
Heterogeneity in direct oral penicillin challenge protocols in penicillin allergy de-labelling
por: Bhogal, Rashmeet, et al.
Publicado: (2021) -
171. Effectiveness and Feasibility of Pharmacist-Driven Penicillin Allergy De-Labeling Pilot Program
por: Song, Youchan, et al.
Publicado: (2020) -
Evaluation of Penicillin Allergies and an Allergy Assessment Pilot in the Emergency Department
por: Norris, Ashlyn, et al.
Publicado: (2021) -
Virtually supported penicillin allergy de-labelling during COVID-19
por: Ghassemian, Arian, et al.
Publicado: (2023) -
1252. Penicillin Allergy Reassessment for Treatment Improvement (PARTI): A Dental Office Tool to Support Appropriate Penicillin Allergy Labeling
por: Coyne, Ashlan J Kunz, et al.
Publicado: (2023)